ClinicalTrials.gg

Program

SYHX2008

A development code. Also written as “SYHX2008 injection”.

Its studies are mostly in Acromegaly, led by CSPC Pharmaceutical Group.

Furthest: phase 3, since May 29, 20264 company-led studies, 2 open or runningNext primary completion: Aug 1, 2027 (phase 2)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
CSPC Pharmaceutical Group42 open or runningphase 3since May 29, 2026Feb 13, 2023Aug 1, 2027phase 2 · NCT06505395

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Feb 13, 2023First study: phase 1 study in AcromegalyFirst studyNCT05761431 · 56 enrolled · China
  2. Jul 10, 2024Phase 2 study in Gastrointestinal Neuroendocrine Pancreatic TumorNCT06505395 · 90 planned · China
  3. May 29, 2026Phase 3 study in Diagnosed With Acromegaly, Currently in the Active Stage of the DiseasePhase 3 reachedNCT07623824 · 154 planned
  4. Sep 7, 2026Phase 2 study in AcromegalyNCT07814651 · 78 enrolled · China

Ahead

  1. Aug 1, 2027Primary completion: phase 2 study in Gastrointestinal Neuroendocrine Pancreatic TumorNCT06505395
  2. Jul 31, 2029Primary completion: phase 3 study in Diagnosed With Acromegaly, Currently in the Active Stage of the DiseaseNCT07623824

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 4 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07814651Acromegaly · China2CompletedApr 9, 202678
NCT07623824Diagnosed With Acromegaly, Currently in the Active Stage of the Disease3Not yet recruitingJul 31, 2029154
NCT06505395Gastrointestinal Neuroendocrine Pancreatic Tumor · China2RecruitingAug 1, 202790
NCT05761431Acromegaly · China1CompletedJun 28, 202356

How it is read

Names in the registry

  • “SYHX2008”, 2 entries
  • “SYHX2008 injection”, 2 entries

Codes read as this program: SYHX2008.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.